As an investment advisory firm with over two decades of experience, we spend a considerable amount of time screening investment products and strategies for our clients.
Essentially, we have two important decisions to make: What should we reject? And what should we select?
Both decisions matter. However, which one contributes more to the long-term success of an investment portfolio?
Interestingly, we believe avoiding bad investments is far more important than constantly searching for the next great investment.
Why?
Because we are human, not divine!
In our endeavour to avoid bad investments, we may occasionally miss some good opportunities. And while selecting good investments, we may sometimes end up choosing a few wrong ones.
That is inevitable.
However, the damage caused by holding unsuitable investments can be significantly more consequential than the opportunity cost of missing a few winners.
This brings us to Warren Buffett's famous two rules of investing:
- Never lose money.
- Never forget Rule No. 1.
At Naveen Rego Capital, we follow a similar philosophy.
Over the years, we have consciously stayed away from several products and strategies that we believe do not fit our investment philosophy or our clients' interests.
Some of the categories we generally avoid include:
- IPOs.
- Unlisted stocks and direct commodities exposure.
- Traditional and market-linked insurance products as investments.
- PMS and AIFs.
- Speculative or inadequately regulated investments, including crypto.
- Direct physical real estate as an investment portfolio allocation.
- Lower-rated bonds and credit strategies.
- Derivatives and leveraged strategies.
- Day trading.
- Collective Investment Schemes, including plantation schemes.
Our decision to stay away from these categories has occasionally cost our clients some potential upside. We acknowledge that.
But it has also helped us significantly reduce exposure to risks that we believe are unnecessary for long-term wealth creation.
So, what do we prefer?
We like keeping investments relatively simple, transparent and understandable.
Our preferred investment universe broadly includes:
- Listed stocks, bonds and ETFs.
- Mutual funds with straightforward equity, debt and hybrid strategies.
- International investments through mutual funds and GIFT City platforms.
- Specialised Investment Funds (SIFs), where the strategy and risks justify their inclusion.
- Real Estate Investment Trusts (REITs), directly or through mutual funds.
- Gold through ETFs and mutual funds.
Of course, even within these preferred categories, we have made mistakes. Some of our product and strategy selections have not delivered the expected results.
We are not claiming to be perfect.
However, by keeping the investment universe relatively simple and avoiding certain categories of investments, the impact of our mistakes has been considerably contained.
Our investment philosophy is simple.
First, protect our clients' wealth from avoidable risks.
Second, grow that wealth through sensible investment decisions.
We probably spend more time rejecting investment opportunities than selecting them.
Because we believe that successful investing is not about owning everything that looks attractive. It is about having the discipline to say NO to most things.
A great investor is not necessarily someone who finds every winner. A great investor is someone who knows what to reject!
If you have missed any of our previous articles, please visit
https://naveenrego.com/blog-grid.php?aW5pdGlhdGl2ZXNfdHlwZV9pZA=MQ
Happy Financial Planning!
Naveen Julian Rego – CFP®
MD & Principal Officer
Naveen Rego Capital
SEBI Registered Investment Adviser
Reg No: INA000019211
BSE Enlistment No: 2178
Disclaimers:
- Investment in the securities market is subject to market risks. Read all related documents before investing.
- Registration granted by SEBI, enlistment as IA with Exchange, and certification from National Institute of Securities Market (NISM) in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.
- Financial products recommended by us that are under the jurisdiction of other regulators are beyond the scope of SEBI’s grievance redressal mechanism.